Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Corvus Pharmaceuticals, Inc. (CRVS)
Sector: Healthcare; Industry: Biotechnology

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-04 MILLER RICHARD A MD President and CEO Buy 35,714 $2.80 $99,999 No
2021-02-17 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 1,285,714 $3.50 $4,499,999 No
2021-02-17 Thompson Peter A. 10%-Owner, Director Buy 1,285,714 $3.50 $4,499,999 No
2021-02-17 MILLER RICHARD A MD President and CEO Buy 100,000 $3.50 $350,000 No
2020-07-08 Novo Holdings A/S 10%-Owner Sell 1,538,062 $5.31 $8,168,547 No
2019-11-13 MILLER RICHARD A MD President and CEO Buy 15,008 $3.00 $45,029 No
2019-08-06 Thompson Peter A. 10%-Owner, Director Buy 142,656 $3.51 $500,723 No
2019-08-06 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 142,656 $3.51 $500,723 No
2019-08-07 MILLER RICHARD A MD President and CEO Buy 7,500 $3.56 $26,725 No
2019-07-25 Novo Holdings A/S 10%-Owner Sell 1,492,956 $4.07 $6,077,845 No
2019-07-01 Thompson Peter A. 10%-Owner, Director Buy 657,344 $3.72 $2,444,065 No
2019-07-01 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 657,344 $3.72 $2,444,065 No
2019-06-14 MILLER RICHARD A MD President and CEO Buy 12,000 $3.41 $40,874 No
2019-06-11 MILLER RICHARD A MD President and CEO Buy 15,212 $3.49 $53,039 No
2019-06-07 LEA LEIV Chief Financial Officer Buy 25,500 $3.49 $88,980 No
2018-12-27 MILLER RICHARD A MD President and CEO Buy 20,000 $3.29 $65,884 No
2018-12-21 LEA LEIV Chief Financial Officer Buy 24,700 $4.15 $102,409 No
2018-12-20 MILLER RICHARD A MD President and CEO Buy 10,000 $4.39 $43,950 No
2018-12-06 MILLER RICHARD A MD President and CEO Buy 5,000 $5.99 $29,934 No
2018-12-04 MILLER RICHARD A MD President and CEO Buy 1,502 $5.95 $8,937 No
2018-03-12 Thompson Peter A. 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2018-03-12 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2018-03-12 Novo Holdings A/S 10%-Owner Buy 1,176,470 $8.50 $9,999,995 No
2018-03-12 Gould Terry P 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2018-03-12 ADAMS STREET PARTNERS LLC 10%-Owner Buy 588,235 $8.50 $4,999,998 No
2018-03-12 MILLER RICHARD A MD President and CEO Buy 100,000 $8.50 $850,000 No
2017-11-20 MILLER RICHARD A MD President and CEO Buy 10,000 $10.79 $107,850 No
2017-06-23 Novo Holdings A/S 10%-Owner Buy 20,000 $10.95 $219,000 No
2017-06-13 MILLER RICHARD A MD President and CEO Buy 25,000 $9.88 $247,084 No
2016-06-24 Thompson Peter A. 10%-Owner, Director Buy 1,000 $12.98 $12,983 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.